Whit Mayo
Stock Analyst at Leerink Partners
(2.52)
# 2,447
Out of 5,102 analysts
152
Total ratings
52.58%
Success rate
10.53%
Average return
Main Sectors:
Stocks Rated by Whit Mayo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACHC Acadia Healthcare Company | Downgrades: Market Perform | $25 → $14 | $14.45 | -3.11% | 11 | Dec 3, 2025 | |
| MD Pediatrix Medical Group | Maintains: Market Perform | $15 → $17 | $22.11 | -23.11% | 11 | Sep 5, 2025 | |
| ELV Elevance Health | Downgrades: Market Perform | $510 → $310 | $360.22 | -13.94% | 4 | Jul 18, 2025 | |
| AIRS AirSculpt Technologies | Maintains: Market Perform | $6.5 → $2.5 | $3.04 | -17.76% | 5 | Mar 31, 2025 | |
| AHCO AdaptHealth | Maintains: Buy | $12 → $11 | $10.25 | +7.32% | 11 | Feb 13, 2025 | |
| EHAB Enhabit | Reiterates: Market Perform | $8.5 → $8 | $9.59 | -16.58% | 2 | Nov 19, 2024 | |
| ARDT Ardent Health | Maintains: Outperform | $23 → $25 | $8.73 | +186.37% | 2 | Nov 12, 2024 | |
| HUM Humana | Downgrades: Market Perform | $400 → $250 | $266.49 | -6.19% | 12 | Oct 2, 2024 | |
| EHC Encompass Health | Initiates: Outperform | $100 | $106.85 | -6.41% | 1 | Jul 10, 2024 | |
| BTSG BrightSpring Health Services | Initiates: Outperform | $15 | $35.90 | -58.22% | 1 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $625 → $560 | $336.73 | +66.31% | 11 | Jun 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $224.58 | - | 11 | May 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $98 → $97 | $129.60 | -25.15% | 1 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $309 → $335 | $272.26 | +23.04% | 5 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $238 → $286 | $482.35 | -40.71% | 17 | Dec 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $55 → $40 | $16.08 | +148.76% | 7 | Nov 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $46 → $39 | $24.82 | +57.13% | 7 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $3 → $1.5 | $2.75 | -45.45% | 4 | Nov 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $33 → $30 | $0.72 | +4,063.78% | 5 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $89 → $55 | $197.71 | -72.18% | 14 | Oct 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $235 → $175 | $90.59 | +93.18% | 1 | Apr 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $19 | $19.41 | -2.11% | 1 | Apr 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $5 → $4 | $3.28 | +21.95% | 6 | Jul 30, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Outperform | $183 → $203 | $264.73 | -23.32% | 2 | May 1, 2018 |
Acadia Healthcare Company
Dec 3, 2025
Downgrades: Market Perform
Price Target: $25 → $14
Current: $14.45
Upside: -3.11%
Pediatrix Medical Group
Sep 5, 2025
Maintains: Market Perform
Price Target: $15 → $17
Current: $22.11
Upside: -23.11%
Elevance Health
Jul 18, 2025
Downgrades: Market Perform
Price Target: $510 → $310
Current: $360.22
Upside: -13.94%
AirSculpt Technologies
Mar 31, 2025
Maintains: Market Perform
Price Target: $6.5 → $2.5
Current: $3.04
Upside: -17.76%
AdaptHealth
Feb 13, 2025
Maintains: Buy
Price Target: $12 → $11
Current: $10.25
Upside: +7.32%
Enhabit
Nov 19, 2024
Reiterates: Market Perform
Price Target: $8.5 → $8
Current: $9.59
Upside: -16.58%
Ardent Health
Nov 12, 2024
Maintains: Outperform
Price Target: $23 → $25
Current: $8.73
Upside: +186.37%
Humana
Oct 2, 2024
Downgrades: Market Perform
Price Target: $400 → $250
Current: $266.49
Upside: -6.19%
Encompass Health
Jul 10, 2024
Initiates: Outperform
Price Target: $100
Current: $106.85
Upside: -6.41%
BrightSpring Health Services
Feb 20, 2024
Initiates: Outperform
Price Target: $15
Current: $35.90
Upside: -58.22%
Jun 14, 2023
Maintains: Outperform
Price Target: $625 → $560
Current: $336.73
Upside: +66.31%
May 26, 2023
Upgrades: Outperform
Price Target: n/a
Current: $224.58
Upside: -
Apr 3, 2023
Maintains: Overweight
Price Target: $98 → $97
Current: $129.60
Upside: -25.15%
Feb 8, 2023
Maintains: Market Perform
Price Target: $309 → $335
Current: $272.26
Upside: +23.04%
Dec 16, 2022
Maintains: Outperform
Price Target: $238 → $286
Current: $482.35
Upside: -40.71%
Nov 22, 2022
Maintains: Outperform
Price Target: $55 → $40
Current: $16.08
Upside: +148.76%
Nov 11, 2022
Maintains: Outperform
Price Target: $46 → $39
Current: $24.82
Upside: +57.13%
Nov 8, 2022
Maintains: Market Perform
Price Target: $3 → $1.5
Current: $2.75
Upside: -45.45%
Nov 4, 2022
Maintains: Outperform
Price Target: $33 → $30
Current: $0.72
Upside: +4,063.78%
Oct 25, 2022
Maintains: Outperform
Price Target: $89 → $55
Current: $197.71
Upside: -72.18%
Apr 4, 2022
Maintains: Overweight
Price Target: $235 → $175
Current: $90.59
Upside: +93.18%
Apr 4, 2022
Initiates: Outperform
Price Target: $19
Current: $19.41
Upside: -2.11%
Jul 30, 2018
Maintains: Neutral
Price Target: $5 → $4
Current: $3.28
Upside: +21.95%
May 1, 2018
Assumes: Outperform
Price Target: $183 → $203
Current: $264.73
Upside: -23.32%